Dermapharm Holding SE buy Ruckelsbuckel
Summary
This prediction ended on 09.08.22 with a price of €55.30. During the runtime of the prediction for Dermapharm Holding SE the price only changed by -0.36%. Ruckelsbuckel has 40% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Dermapharm Holding SE | -3.438% | -3.438% | -11.362% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
According to Ruckelsbuckel what are the pros and cons of Dermapharm Holding SE for the foreseeable future?
Pros
Cons
Comments by Ruckelsbuckel for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE